# A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib

> **NCT02311946** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Palbociclib Alone
- **DRUG:** Palbociclib + Rabeprazole

## Key facts

- **NCT ID:** NCT02311946
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311946, "A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02311946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*